선천성 근성 사견의 A형 보툴리눔 독소 국소 주사치료

초록

Local Botulinum Toxin Type A Injection for the Management of Congenital Muscular Torticollis. Jo, Ho Sung , Kang, Yoon Kyoo , Paik, Kyung Woo , Kim, Dong Hwee , Hwang, Mi Ryoung , Kim, Ki Hoon Department of Rehabilitation Medicine, Korea University College of Medicine, Ansan Hospital, Kyungki-do, Korea. yykang@unitel.co.kr 선천성 근성 사경의 A형 보툴리눔 독소 국소 주사치료 조호성·강윤규·백경우·김동휘·황미령·김기훈 고려대학교 의과대학 재활의학교실 Abstract Objective To evaluate the effectiveness of local intramuscular botulinum toxin type A injection in patients with congenital muscular torticollis. Method Six patients (mean age, 13.3 months) with congenital muscular torticollis who did not respond to physical therapy were participated with the informed consent of their parents. Twenty-five to fifty Speywood units of Dysport (Beaufour Ipsen, France) were injected into the palpated mass of the sternocleidomastoid muscle. The angle of tilt and range of motion of the neck in sitting position were obtained before and after injection. The size of the mass within the sternocleidomastoid muscle was measured with ultrasonogram. Results Satisfactory improvement of 3 parameters at post- injection 6-month follow-up was achieved in all patients. The tilting angle and range of motion of the neck to rotation were normalized in 5 patients. The size of the mass within the sternocleidomastoid muscle was decreased significantly with ultrasonographic evaluation. Conclusion Local intramuscular BTA injection might be effective for patients with congenital muscular torticollis who do not respond to conservative management. (J Korean Acad Rehab Med 2002; 26: 699-703)

키워드